Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | 19(T2)28z1xx TRAC CAR-T cells |
Trade Name | |
Synonyms | |
Drug Descriptions |
19(T2)28z1xx TRAC CAR-T cells are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD19 and also containing mutated immunoreceptor tyrosine-based activation motifs, which potentially leads to antitumor activity (Blood (2020) 136 (Supplement 1): 43-44). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
19(T2)28z1xx TRAC CAR-T cells | 19(T2)28z1xx TRAC CAR-T cells | 0 | 1 |